Antiangiogenic and antitumor activities of peptide inhibiting the vascular endothelial growth factor binding to neuropilin-1
- 16 August 2006
- journal article
- Published by Elsevier BV in Life Sciences
- Vol. 79 (25), 2370-2381
- https://doi.org/10.1016/j.lfs.2006.08.005
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- A peptide corresponding to the neuropilin-1-binding site on VEGF165 induces apoptosis of neuropilin-1-expressing breast tumour cellsBritish Journal of Cancer, 2005
- Anti-chemorepulsive Effects of Vascular Endothelial Growth Factor and Placental Growth Factor-2 in Dorsal Root Ganglion Neurons Are Mediated via Neuropilin-1 and Cyclooxygenase-derived Prostanoid ProductionPublished by Elsevier BV ,2004
- Tumorigenesis and the angiogenic switchNature Reviews Cancer, 2003
- Identification of a peptide blocking vascular endothelial growth factor (VEGF)-mediated angiogenesisThe EMBO Journal, 2000
- The Hallmarks of CancerCell, 2000
- Vascular Endothelial Growth Factor Effect on Endothelial Cell Proliferation, Migration, and Platelet-activating Factor Synthesis Is Flk-1-dependentJournal of Biological Chemistry, 1999
- An in vitro model of angiogenesis: Basic featuresAngiogenesis, 1999
- Patterns and Emerging Mechanisms of the Angiogenic Switch during TumorigenesisCell, 1996
- Angiogenesis in cancer, vascular, rheumatoid and other diseaseNature Medicine, 1995
- Lectin histochemistry of mammalian endotheliumHistochemistry and Cell Biology, 1987